Cellular genes capable of inducing cell transformation have been isolated from animal and human tumors (for reviews, see references 5 and 35). These oncogenes can be activated by point mutation, gene amplification. chromosomal translocation, or enhanced gene expression.
Cellular oncogenes of two distinct complementation groups represented by the mnwc and the ras family are capable together of transforming primary fibroblasts in vitro (18, 27) . The rias genes, which have NIH 3T3 cell-transforming activity, are mutationally activated (15. 26. 31, 32) , whereas most examples of active myc-genes involve chromosomal translocations or gene amplification (9. 17. 20, 25) .
Ionizing radiation is a potent and well-characterized carcinogen for rat skin (8a) . Several types of carcinomas develop in rat skin after localized exposure to single or fractionated doses of ionizing radiation (1). The molecular mechanism(s) by which ionizing radiation leads to tumorigenesis is not known. The reported genotoxic effects of ionizing radiation include primarily chromosomal aberrations and DNA strand breaks (19; Burns and Albert, in press). The misrepair of these lesions could result in chromosomal rearrangements or translocations (19) .
Guerrero et al. (14) demonstrated the activation of a c-K-ras oncogene by somatic mutations in mouse lymphomas induced by gamma radiation. Increased myc gene expression has been seen in human WI38 cells transformed by ionizing radiation (23) . We report here evidence for activation of both c-K-ras and c-myc oncogenes in individual primary rat skin tumors induced by ionizing radiation.
Male Sprague-Dawley rats were exposed at 4 weeks of age to 0.8 MeV of electron radiation (maximum skin penetration. 1.0 mm) in single or multiple doses r-anging from 800 to 160()0 rads. The skin tumors arising 46 (Fig. 1) . DNA from nude mouse tumors and secondary transfectants also showed rat-derived K-ras bands (Fig. 1) . Similar experiments, using N-and H-ras probes, revealed only the endogenous mouse fragments in transfectant DNA (data not shown). Primary tumor DNA from the same panel of rat skin tumors was used to examine myc gene activation. Southern hybridization (Fig. 2) of BanziHI-digested tumor DNAs to a third-exon human c-myc probe (a gift of R. Dalla-Favera) revealed gene amplification and restriction polymorphism in 10 of the 12 tumors. The myc gene was amplified 5-to 20-fold by densitometric analysis; the extensive restriction polymorphism seen in BamHI digests of most of the tumor DNAs was also seen after EcoRI and HindlIl digestion. Hybridization of the same filters to N-myc (Fig. 3) , K-ras, and H-ras (data not shown) probes failed to detect any differences in the intensity or number of restriction fragments of these genes in tumors compared with normal rat DNA. Tissue from six of the tumors, as well as from normal rat epidermis, was available for preparation of poly(A)+ RNA (2, 10). Northern and dot blot analyses of these tumor RNAs revealed evidence for enhanced c-myc expression in amplification-positive tumors. There was a qualitative correlation between c-myc gene amplification on the basis of Southern analysis and c-myc gene expression in these tumors; however, this correlation was not quantitative ( Table 2 ). The level of c-myc expression in rat epidermis was very low compared with that of other genes, such as H-ras, as shown by rehybridization of filters to other gene probes. No differences in H-ras or K-ras gene expression were seen in any tumor compared with rat epidermis (data not shown).
Concurrent activation of K-ras and c-myc oncogenes was found in three of the tumors examined (RAD 4, RAD 5, and RAD 8). Transfectant DNA was not available from tumor RAD 1 to specifically identify activation of K-ras; however, the transfection results (Table 1) suggest that ras activation, as well as myc amplification (Fig. 2) , has occurred in this tumor. Evidence for alterations in the c-myc gene was found in the six tumors which were negative in the NIH 3T3 focus assay but was not found in two tumors that were positive in transfection. No correlation was seen between oncogene activation parameters and the size or growth rate of tumors or radiation dose or age of animal at sacrifice.
The reported genotoxic effects of ionizing radiation include primarily chromosomal aberrations and DNA strand breaks (8a), as opposed to the point mutations often found with certain chemical carcinogens, such as MNU (21) . Chromosomal translocations of the type that could occur as a result of the genotoxic effects of radiation on target cells have been shown to result in activation of the inyc oncogene by promoter insertion in Burkitt's lymphoma (9) . The pattern of extensive restriction polymorphism of the myc gene in most of the radiation tumor DNAs suggests the occurrence of frequent rearrangements of this gene or amplifica- hybridized to an N-rnvc (Oncor) probe.
tion of other myc-related genes in radiation-induced tumors. Therefore, the results are consistent with the known effects of ionizing radiation on target DNA and the known mechanisms of myc activation, which also include gene amplification. The lack of quantitative correlation between apparent gene amplification and expression (Table 2) is difficult to explain without more information concerning the precise nature of the molecular alterations involved in c-myc activation in these tumors. Similar results were reported previously (28) .
It may be significant that the NIH-3T3-transforming oncogene (K-ras) activated in rat skin carcinomas was the same as the one found in radiation-induced mouse thymic lymphomas (14) . In contrast, chemically induced mouse skin carcinomas (3, 7), as well as other tumors of epithelial origin (11, 30) , contain activated H-ras. These results imply selectivity toward activation of particular ras genes by specific carcinogenic agents, such as ionizing radiation. Evidence for carcinogen specificity in transforming oncogene activation in Purified poly(A1) RNA was denatured in glyoxal (22) , and Northern (34) or dot blots were hybridized with the same c-mvc probe used in Fig. 2. experimental tumors has been observed in other systems (12, 13, 37 ).
There appears to be a tissue-specific component in oncogene activation in this system. Tumors may arise from several of the many cell types present in rat epidermis after exposure to carcinogenic doses of ionizing radiation (1, 8a). In the current study, each of the three clear cell carcinomas exhibited activation of both ras and myc oncogenes, whereas in four of the five squamous cell carcinomas only mnyc alterations were seen. This pattern suggests that the particular program of multiple oncogene activation involved in tumorigenesis may vary on the basis of cell type.
There is a great deal of evidence that carcinogenesis is a multistep process (6, 8) . The finding that at least two active oncogenes are required to transform primary fibroblasts (18, 27) (16) .
Activation of ras and myc oncogenes has been reported in individual human tumors and tumor cell lines (24, 33) . In this report, concurrent multiple oncogene activation was found in a panel of primary tumors induced by a single, welldefined etiological agent. Our results provide strong evidence for the hypothesis (35) that activation of multiple oncogenes of different complementation groups may contribute to carcinogenesis in animals and humans. The use of animal tumor models has led to important insights into the molecular mechanisms by which carcinogenic agents may activate cellular oncogenes (37 
